Blood coagulation mold and manufacturing process thereof

By designing a coagulation mold assembly, which utilizes internal and external attachments to ensure sterility and facilitate the application of blood clots, the problems of sterility maintenance and application of coagulation molds are solved, thus improving treatment outcomes.

CN119012988APending Publication Date: 2024-11-22REDDRESS LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380033254.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-12
Filing Date
2023-04-04
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing coagulation molds are difficult to maintain aseptic conditions during use and are difficult to effectively apply the formed blood clots to the target.

Method used

A coagulation mold assembly was designed, comprising a coagulation mold, a blood clot support substrate, and a removable closure. The internal and external attachments ensure sterility of the mold cavity and facilitate its application to the target after clot formation.

Benefits of technology

This allows for the formation of blood clots under sterile conditions and their convenient application to targets, thus improving treatment outcomes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119012988A_ABST
    Figure CN119012988A_ABST
Patent Text Reader

Abstract

The present disclosure provides blood clotting mold assemblies and methods for making the same. The blood clotting mold assembly is intended to be filled with whole blood and allow blood to clot within its mold cavity to obtain a blood clot which is subsequently applied on an injured portion, such as a skin lesion, for assisting its recovery. The blood clotting mold assembly includes a blood clotting mold having a mold cavity containing one or more blood clotting initiators into which blood is introduced to form blood clots, thereby forming a blood clotting space. The blood clotting mold includes a peripheral portion extending from a wall of the mold cavity in an outward direction relative to the mold cavity. A blood clot support substrate is formed over the opening of the mold cavity to allow it to contact blood within the cavity such that blood clots formed within the cavity adhere to the support substrate. A removable closure adapted to maintain a sterile condition within the mold cavity is attached to the blood clotting mold at two attachment portions, including an inner attachment portion and an outer attachment portion. The inner attachment portion surrounds the mold cavity and a portion of the support base is disposed in the inner attachment portion, i.e. The support base is sandwiched between the blood clotting mold and the removable closure and held in a desired position. The internal attachment portion also provides a sealing action for blood introduced into the mold cavity to maintain it limited to the mold cavity. Note that the attachment does not need to provide a hermetic seal and only needs to ensure that a majority of the blood remains within the mold cavity. The outer attachment portion surrounds the inner attachment portion and provides a sterile seal to maintain the mold cavity sterile.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure is in the field of medical devices, particularly in the field of medical devices that utilize blood. Background Art

[0002] The following is a list of references that are believed to be relevant to the background of the presently disclosed subject matter:

[0003] -US 9,180,142

[0004] -WO 2019 / 058375

[0005] -WO 2021 / 124317.

[0006] Acknowledgment herein of the above references should not be inferred as an intention that these references are in any way relevant to the patentability of the presently disclosed subject matter. Summary of the invention

[0007] The present disclosure provides a blood coagulation mold assembly and a method for manufacturing the same. The blood coagulation mold assembly is intended to be filled with whole blood and allow the blood to coagulate in its mold cavity to obtain a blood clot, which is then applied to an injured part to help it recover. For example, the clot formed in the blood coagulation mold assembly can be applied to any type of skin lesion to enhance its recovery. The blood coagulation mold assembly includes a blood coagulation mold having a mold cavity containing one or more coagulation initiators, in which blood is introduced to form a blood clot, thereby forming a coagulation space. The blood coagulation mold includes a peripheral portion extending from the wall of the mold cavity in an outward direction relative to the mold cavity. A blood clot support matrix is ​​formed above the opening of the mold cavity to allow it to contact the blood in the cavity, so that the blood clot formed in the cavity adheres to the support matrix. A removable closure suitable for maintaining sterile conditions in the mold cavity is attached to the blood coagulation mold at two attachment parts (including an inner attachment part and an outer attachment part). The inner attachment portion surrounds the mold cavity and the portion of the support substrate is arranged in the inner attachment portion, that is, the support substrate is sandwiched between the coagulation mold and the removable closure and is maintained in the desired position. The inner attachment portion also provides a sealing effect (sealing) for the blood introduced into the mold cavity to maintain it confined to the mold cavity. It should be noted that the attachment does not need to provide an airtight seal (hermetic seal), only to ensure that most of the blood remains in the mold cavity. However, in some embodiments, the inner attachment is sealed so that the blood is prevented from being transferred from the mold cavity to the peripheral portion through the inner attachment. The outer attachment portion surrounds the inner attachment portion and provides a sterile seal to maintain the mold cavity sterile.

[0008] Therefore, the first aspect of the present disclosure provides any one of the following two configurations.

[0009] The first configuration provides a coagulation mold assembly. The coagulation mold assembly includes a coagulation mold, the coagulation mold including a mold cavity defined between the walls of the body and having an opening defined by the end portion of the wall of the body. The mold cavity is configured to allow blood to be introduced therein. The introduction of blood can be accomplished by injecting blood through the wall defining the mold cavity or through a predetermined port formed in the wall defining the mold cavity. The coagulation mold also includes a peripheral portion extending from the entire periphery of the end portion of the wall of the body, and the peripheral portion is integral with the body and is generally planar. The peripheral portion extends outwardly from the mold cavity and forms a suitable placement surface for placing the coagulation mold assembly.

[0010] A removable closure is formed over the opening of the mold cavity and over at least a portion of the peripheral portion. The removable closure is intended to be removed after blood has coagulated in the mold cavity, thereby exposing the clot and allowing it to be applied to a desired target (e.g., a skin lesion).

[0011] The coagulation mold assembly also includes a clot support matrix or sheet held between the mold cavity and the removable closure such that at least a first portion thereof is positioned at the opening and at least a second portion thereof is positioned at the peripheral portion. The removable closure is attached to the peripheral portion of the coagulation mold at two attachment portions surrounding the mold cavity, the attachment portions including: an outer attachment portion, wherein the attachment is directly between the removable closure and the coagulation mold for obtaining sterile conditions within the mold cavity; and an inner attachment portion, which is between the outer attachment portion and the body, wherein the clot support matrix is ​​intermediate at least a portion of the inner attachment portion for holding the clot support matrix in a desired position above the opening while a clot is formed in the mold cavity.

[0012] The structure allows blood to be introduced into the sterile mold cavity through the wall of the body (by piercing it with a syringe or through a predetermined port) and allows a blood clot to be formed within the sterile mold cavity. The blood clot adheres to the blood clot support matrix and can be carried with it. After the blood clot is formed, the removable closure is removed and the exposed blood clot can be easily lifted by lifting the blood clot support matrix from its peripheral portion that is retained outside the mold cavity (i.e., the portion retained by the internal attachment portion and its periphery). After the blood clot is lifted, it can be placed on any desired target (e.g., skin lesions).

[0013] A second configuration provides a coagulation mold assembly. The coagulation mold includes a coagulation mold, the coagulation mold including a mold cavity defined between the walls of the body and having an opening, the end portion of the wall of the body defining the opening. The mold cavity is configured for introducing blood therein. The coagulation mold also includes a peripheral portion extending from the entire periphery of the end portion of the wall of the body, and the peripheral portion is integral with the body and is generally planar. The peripheral portion extends outwardly from the mold cavity and forms a suitable placement surface for placing the coagulation mold assembly.

[0014] The removable closure is formed over the opening and over at least a portion of the peripheral portion, and is attached to the coagulation mold at at least two attachment portions of the peripheral portion, the at least two attachment portions comprising an inner attachment portion and an outer attachment portion. Each attachment portion forms a closed frame, i.e., each attachment portion limits an inner space or inner portion. The inner attachment portion is formed between the outer attachment portion and the body, and the outer attachment portion provides a sterile separation between the environment and the mold cavity.

[0015] The clot supporting matrix or sheet is retained between the mold cavity and the removable closure at the interior attachment portion such that at least a first portion thereof is positioned at the opening and at least a second portion thereof is positioned at the peripheral portion.

[0016] After blood is introduced into the mold cavity by piercing the wall of the body or through a predetermined port formed in the wall, the blood coagulates in the mold cavity and at least a portion of the blood is retained by or attached to the clot support matrix or sheet. The removable closure is then removed to expose the clot and allow it to be applied to a desired target (e.g., skin lesion) together with the clot support matrix or sheet.

[0017] It should be noted that any combination of the embodiments described with respect to any aspect or configuration of the present disclosure is applicable. In other words, any aspect of the present disclosure can be defined by any combination of the embodiments described.

[0018] In some embodiments of the coagulation mold assembly, the mold cavity comprises a coagulation initiator for initiating coagulation of blood introduced therein.

[0019] In some embodiments of the coagulation mold assembly, the coagulation initiator is in powder form.

[0020] In some embodiments of the coagulation mold assembly, the coagulation initiator comprises a coagulant, an anticoagulant, or both.

[0021] In some embodiments of the coagulation mold assembly, the anticoagulant is selected from the group consisting of: ACD-A (anticoagulant citrate dextrose, solution A), EDTA (ethylenediaminetetraacetic acid), EGTA (ethylene glycol tetraacetic acid), citrate, heparin, and oxalate.

[0022] In some embodiments of the coagulation mold assembly, the coagulant or anti-anticoagulant is selected from: kaolin, Ca 2+ Mg 2+ , negatively charged phospholipids (PL) and protamine sulfate.

[0023] In some embodiments of the coagulation mold assembly, the wall of the body defining the mold cavity is designed to allow blood to be introduced into the mold cavity through it. For example, blood can be introduced into the mold cavity by injecting blood through the wall with a syringe.

[0024] In some embodiments of the coagulation mold assembly, a port is formed in the wall of the body to allow blood to be introduced therethrough into the mold cavity.

[0025] In some embodiments of the coagulation mold assembly, the peripheral portion is integral with the body.

[0026] In some embodiments of the coagulation mold assembly, the peripheral portion is generally planar such that it is suitable for placement on a surface to perform a coagulation process.

[0027] In some embodiments of the coagulation mold assembly, the clot-supporting substrate is a sheet or gauze.

[0028] In some embodiments of the coagulation mold assembly, at least a portion of the clot-supporting matrix is ​​retained or preserved throughout the entire opening of the mold cavity.

[0029] In some embodiments of the coagulation mold assembly, the inner attachment portion is defined to be located at a periphery of the wall of the body, ie, the inner attachment portion is adjacent to and surrounds the wall of the body.

[0030] In some embodiments of the coagulation mold assembly, the peripheral portion includes a first abutment extending from a wall of the body (particularly from an end portion of the wall) toward the periphery. The first abutment extends to a certain extent, defining a first abutment width. The first abutment defines an inner attachment portion, i.e., attached to a top portion of the first abutment.

[0031] In some embodiments of the coagulation mold assembly, the peripheral portion includes a second connection portion defining an outer attachment portion, ie, attached to a top portion of the first connection portion.

[0032] In some embodiments of the coagulation mold assembly, the removable closure is a synthetic flash spun high density polyethylene fiber sheet.

[0033] In some embodiments of the coagulation die assembly, the removable closure is a nonwoven product composed of spunbond olefin fibers.

[0034] In some embodiments of the coagulation mold assembly, the attachment portion is formed by heat welding.

[0035] In some embodiments of the coagulation mold assembly, the attachment portion is formed by ultrasonic welding.

[0036] In some embodiments of the coagulation mold assembly, at least one of the wall of the mold cavity and the closure is pierceable by a needle or includes a port (eg, a one-way port) for allowing blood to be introduced into the cavity.

[0037] In some embodiments of the coagulation mold assembly, the external attachment portion is sealed to prevent contaminants from entering between the removable closure and the peripheral portion toward the mold cavity. Contaminants are considered to be particles or organisms larger than a certain size that may adversely affect the blood clot formed in the mold cavity. The sealing effect formed by the external attachment portion ensures that the mold cavity remains sterile before blood is introduced therein.

[0038] In some embodiments of the coagulation mold assembly, the outer attachment portion provides a sterile separation between the environment and the mold cavity. The coagulation mold and the removable closure are made of materials suitable for providing a sterile separation, and the outer attachment provides an attachment between the peripheral portion and the removable closure in a sterile manner, ensuring that the mold cavity remains sterile before blood is introduced therein.

[0039] Another aspect of the present disclosure provides a method for manufacturing a coagulation mold assembly. The method comprises:

[0040] (i) Providing a coagulation mold, the coagulation mold comprising a mold cavity defined between the walls of the body and having an opening defined by the end portion of the wall of the body. The mold cavity is configured for introducing blood therein. The coagulation mold also comprises a peripheral portion extending from the entire periphery of the end portion of the wall of the body in an outward direction to the mold cavity. The peripheral portion is integral with the body and is generally planar.

[0041] (ii) placing the clot supporting substrate on the coagulation mold so that at least a first portion thereof is placed on the opening and at least a second portion thereof is placed on the peripheral portion.

[0042] (iii) attaching the removable closure to the peripheral portion at two attachment portions forming a closed frame around the mold cavity, the attachment portions comprising: an outer attachment portion, wherein the attachment is directly between the removable closure and the coagulation mold for obtaining sterile conditions within the mold cavity; and an inner attachment portion, which is formed between the outer attachment portion and the body. The clot support matrix is ​​sandwiched between the peripheral portion and the removable closure at at least a portion of the inner attachment portion for holding the clot support matrix in a desired position above the opening while a clot is formed in the mold cavity.

[0043] In some embodiments, the method includes introducing a clotting initiator into the mold cavity prior to said attaching.

[0044] In some embodiments of the method, the coagulation initiator is in powder form.

[0045] In some embodiments of the method, the coagulation initiator comprises a coagulant, an anticoagulant, or both.

[0046] In some embodiments of the method, the anticoagulant is selected from the group consisting of: ACD-A (anticoagulant citrate dextrose, solution A), EDTA (ethylenediaminetetraacetic acid), EGTA (ethylene glycol tetraacetic acid), citrate, heparin, and oxalate.

[0047] In some embodiments of the method, the coagulant or anti-anticoagulant is selected from the group consisting of: kaolin, Ca 2+Mg 2+ , negatively charged phospholipids (PL) and protamine sulfate.

[0048] In some embodiments of the method, the wall of the body defining the mold cavity is designed to allow blood to be introduced into the mold cavity through it. For example, blood can be introduced into the mold cavity by injecting blood through the wall with a syringe.

[0049] In some embodiments of the method, a port is formed in the wall of the body to allow blood to be introduced therethrough into the mold cavity.

[0050] In some embodiments of the method, the peripheral portion is integral with the body.

[0051] In some embodiments of the method, the peripheral portion is substantially planar.

[0052] In some embodiments of the method, the clot-supporting substrate is a sheet or gauze.

[0053] In some embodiments of the method, the placing is performed such that at least a portion of the clot supporting matrix is ​​placed across the entire opening of the mold cavity.

[0054] In some embodiments of the method, the inner attachment portion is defined to be located at a periphery of the wall of the body, ie, the inner attachment portion is adjacent to and surrounds the wall of the body.

[0055] In some embodiments, the method includes pressing the coagulation mold against the removable closure to form a first connection extending from the wall of the body toward the periphery, the interior attachment portion being defined at the first connection.

[0056] In some embodiments, the method includes pressing the coagulation mold against the removable closure to form a second connection, the external attachment portion being defined at the second connection.

[0057] In some embodiments of the method, the removable closure is a sheet of flash spun high density polyethylene fibers.

[0058] In some embodiments of the method, the removable closure is a nonwoven product comprised of spunbond olefin fibers.

[0059] In some embodiments of the method, the attaching includes heat welding the attached portions.

[0060] In some embodiments of the method, the attaching comprises ultrasonically welding the attachment portion.

[0061] In some embodiments of the method, at least one of the wall of the mold cavity and the closure is pierceable by a needle or includes a port (eg, a one-way port) for allowing blood to be introduced into the cavity.

[0062] In some embodiments of the method, the attachment results in a sealing action, thereby forming a seal that prevents contaminants from entering between the removable closure and the peripheral portion toward the mold cavity. Contaminants are considered to be particles or organisms larger than a certain size that may adversely affect the blood clot formed in the mold cavity. The sealing action formed by the external attachment portion ensures that the mold cavity remains sterile before blood is introduced therein.

[0063] In some embodiments of the method, the attachment results in a sterile separation between the environment and the mold cavity. The coagulation mold and the removable closure are made of materials suitable for providing a sterile separation, and the external attachment provides an attachment between the peripheral portion and the removable closure in a sterile manner, ensuring that the mold cavity remains sterile before blood is introduced therein. BRIEF DESCRIPTION OF THE DRAWINGS

[0064] For a better understanding of the subject matter disclosed herein and in order to illustrate how the same may be implemented in practice, embodiments will now be described, by way of non-limiting examples only, with reference to the accompanying drawings, in which:

[0065] Figures 1A to 1B Schematic diagrams of different views of one non-limiting example of one embodiment of a coagulation mold assembly according to the present disclosure. Figure 1A is a top view of the coagulation mold assembly and Figure 1B It is a cross-sectional view of the coagulation mold assembly. DETAILED DESCRIPTION

[0066] The following figures are provided to illustrate some embodiments and implementations of the invention of the present disclosure.

[0067] refer to Figures 1A to 1B , which is a schematic diagram of different views of one non-limiting example of one embodiment of a coagulation mold assembly according to the present disclosure. The coagulation mold assembly 100 includes a coagulation mold 101, which includes a mold cavity 102 defined between walls 104 of a body 105, and in this example, the walls 104 are concave. It should be noted that the walls can be any shape that defines a space. The opening 106 of the mold cavity 102 is defined by the end 108 of the wall 104. The coagulation mold 101 also includes a peripheral portion 110 extending from the end 108 of the wall 104 in a direction away from the mold cavity 102, that is, the peripheral portion 110 extending laterally away from the mold cavity 102. The peripheral portion 110 is generally planar, except for the attachment portion as described in detail below.

[0068] A removable closure 112 (e.g., a flash-spun high-density polyethylene fiber sheet membrane) is attached to the peripheral portion 110 at two attachment portions, an inner attachment portion 114 and an outer attachment portion 116. The two attachment portions form a closed path, i.e., the attachment portions fully surround the mold cavity 102, and each attachment portion is at a different distance from the mold cavity 102. The removable closure 112 is required to provide a sterile separation between the environment and the interior of the mold cavity 102 before the coagulation mold assembly 100 is used.

[0069] One or more clotting initiators 118 are contained within the confined space of the mold cavity 102 to allow clotting when blood is introduced therein. The blood may be introduced by piercing a portion of the wall 104 of the mold cavity 102 or through a port (eg, a one-way port formed in the wall 104).

[0070] The clot support matrix 120 is disposed between the removable closure 112 and the coagulation mold 101 such that at least a first portion 121 thereof is positioned at the opening 106 and a second portion 123 thereof is positioned at a portion of the internal attachment portion 114. In this example, the clot support matrix 120 is positioned along the entire circumference of the internal attachment portion 114. Thus, the attachment between the removable closure 112 and the coagulation mold 101 holds the clot support matrix 120 in one or more portions. This configuration helps maintain the clot support matrix 120 in a suitable position so that it is immersed in or at least in contact with the coagulating blood in the mold cavity 102 when blood is introduced to form a clot. Since the coagulation process is performed when the coagulation mold assembly 100 is placed on a surface so that the removable closure faces and engages with the surface, blood is present on one side of the clot support matrix 120 and the formed clot adheres to the clot support matrix 120 to promote the transformation of the clot to the desired therapeutic target.

[0071] In this example, each of the two attachment parts 114 and 116 is composed of a connection 124 and 126, respectively, which is formed by a hot pressure welding technique. It should be noted that other attachment techniques can be used, such as ultrasonic welding, gluing, etc. The internal attachment part 114 is annular and is formed around the end 108 of the wall 104 of the mold cavity 102. The external attachment part 116 is rectangular, but it should be understood that it can be any closed shape: a sealed sterile space is created between the removable closure 112 and the coagulation mold 101 in any part of the external attachment part 116 inward in the direction of the mold cavity 102 (i.e., all parts between the external attachment part 116 and the mold cavity 102, including some parts sandwiched between the removable closure 112 and the peripheral part 110).

[0072] The purpose of the outer attachment portion 116 is to maintain the sterility of the mold cavity before it is used, and the purpose of the inner attachment portion 114 is to retain the clot supporting matrix 120 and prevent blood from leaking out of the mold cavity 102 during the coagulation process.

[0073] To use the coagulation mold assembly, whole blood is introduced into the mold cavity 102 and the coagulation process is initiated. After the blood coagulates and the clot support matrix 120 adheres thereto, the removable closure 112 is removed and the clot carried on the clot support matrix 120 is transferred and placed on a treatment target (e.g., a skin lesion).

Claims

1. A blood coagulation mold assembly, comprising: A blood coagulation mold comprising: a mold cavity defined between the walls of the body and having an opening, the mold cavity being configured for introducing blood therein, and a peripheral portion extending from the entire periphery of the end of the wall of the body; a removable closure formed over at least a portion of the peripheral portion and the opening, and attached to the coagulation mold at at least two attachment portions of the peripheral portion, the at least two attachment portions comprising an inner attachment portion and an outer attachment portion each forming a closure frame, wherein the inner attachment portion is formed between the outer attachment portion and the body; A clot supporting matrix is ​​retained between the mold cavity and the removable closure at the interior attachment portion such that at least a first portion thereof is positioned at the opening and at least a second portion thereof is positioned at the peripheral portion.

2. The coagulation mold assembly of claim 1, wherein the mold cavity contains a coagulation initiator for initiating coagulation of blood introduced therein.

3. The coagulation mold assembly of claim 1 or 2, wherein the peripheral portion is integral with the main body.

4. The coagulation mold assembly of any one of claims 1 to 3, wherein the peripheral portion is generally planar.

5. The coagulation mold assembly of any one of claims 1 to 4, wherein the blood clot supporting substrate is a sheet or gauze.

6. The coagulation mold assembly of any one of claims 1 to 5, wherein at least a portion of the clot support matrix is ​​maintained throughout the entire opening of the mold cavity.

7. The coagulation mold assembly of any one of claims 1 to 6, wherein the inner attachment portion is defined to be located at an outer periphery of a wall of the body.

8. The coagulation mold assembly of any one of claims 1 to 7, wherein the peripheral portion includes a first connection portion extending from a wall of the body toward the periphery, the first connection portion defining the inner attachment portion.

9. The coagulation mold assembly of any one of claims 1 to 8, wherein the peripheral portion includes a second connection portion defining the external attachment portion.

10. The coagulation mold assembly of any one of claims 1 to 9, wherein the removable closure is a flash spun high density polyethylene fiber sheet.

11. The coagulation mold assembly of any one of claims 1 to 10, wherein the attachment portion is formed by heat welding.

12. The coagulation mold assembly of any one of claims 1 to 10, wherein the attachment portion is formed by ultrasonic welding.

13. The coagulation mold assembly of any one of claims 1 to 12, wherein at least one of the wall and closure of the mold cavity is pierceable by a needle or includes a port for allowing blood to be introduced into the cavity.

14. The coagulation mold assembly of any one of claims 1 to 13, wherein the external attachment portion is sealed to prevent contaminants from entering between the removable closure and the peripheral portion toward the mold cavity.

15. The coagulation mold assembly of any one of claims 1 to 14, wherein the external attachment portion provides a sterile separation between an environment and the mold cavity.

16. A method for making a coagulation mold assembly, comprising: A blood coagulation mold is provided, the blood coagulation mold comprising: a mold cavity defined between the walls of the body and having an opening, the mold cavity being configured for introducing blood therein, and a peripheral portion extending from the entire periphery of the end of the wall of the body; placing a blood clot support substrate on the blood coagulation mold so that at least a first portion thereof is placed on the opening and at least a second portion thereof is placed on the peripheral portion; The removable closure is attached to the peripheral portion at two attachment portions surrounding the mold cavity, the attachment portions comprising an outer attachment portion and an inner attachment portion, wherein the inner attachment portion is formed between the outer attachment portion and the body, and wherein the blood clot supporting matrix is ​​clamped between the peripheral portion and the removable closure at at least a portion of the inner attachment portion so as to be held in an appropriate position.

17. The method of claim 16, comprising introducing a clotting initiator into the mold cavity prior to said attaching.

18. The method of claim 16 or 17, wherein the peripheral portion is integral with the body.

19. The method of any one of claims 16 to 18, wherein the peripheral portion is generally planar.

20. The method of any one of claims 16 to 19, wherein the clot supporting matrix is ​​a sheet or gauze.

21. The method of any one of claims 16 to 20, wherein the placing is performed such that at least a portion of the clot supporting matrix is ​​placed over the entire opening of the mold cavity.

22. The method of any one of claims 16 to 21, comprising pressing the coagulation mold against the removable closure to form a first connection extending from the wall of the body toward the periphery, the inner attachment portion being defined at the first connection.

23. The method of any one of claims 16 to 22, comprising pressing the coagulation mold against the removable closure to form a second connection, the external attachment portion being defined at the second connection.

24. The method of any one of claims 16 to 23, wherein the peripheral portion includes a second connection portion defining the external attachment portion.

25. The method of any one of claims 16 to 24, wherein the removable closure is a sheet of flash spun high density polyethylene fibers.

26. The method of any one of claims 16 to 25, wherein the attaching comprises heat welding the attachment portion.

27. The method of any one of claims 16 to 26, wherein the attaching comprises ultrasonically welding the attachment portion.

28. The method of any one of claims 16 to 27, wherein the attaching results in a sealing action, thereby forming a seal such that contaminants are prevented from entering between the removable closure and the peripheral portion towards the mould cavity.

29. The method of any one of claims 16 to 28, wherein the attachment results in a sterile separation between an environment and the mold cavity.

30. The method of any one of claims 16 to 29, wherein at least one of the wall of the mould cavity and the closure is pierceable by a needle or comprises a port for allowing blood to be introduced into the cavity.

31. A blood coagulation mold assembly, comprising: A blood coagulation mold comprising: a mold cavity defined between the walls of the body and having an opening, the mold cavity being configured for introducing blood therein, as well as a peripheral portion extending from the entire periphery of the end of the wall of the body; a removable closure formed over at least a portion of the peripheral portion and the opening, and attached to the coagulation mold at at least two attachment portions of the peripheral portion, the at least two attachment portions comprising an inner attachment portion and an outer attachment portion each forming a closure frame, wherein the inner attachment portion is formed between the outer attachment portion and the body; A clot supporting matrix is ​​retained between the mold cavity and the removable closure at the interior attachment portion such that at least a first portion thereof is positioned at the opening and at least a second portion thereof is positioned at the peripheral portion.